Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

BioMed Central Publishes Framingham Heart Study 100K Result

20.09.2007
BioMed Central, the world's largest publisher of peer-reviewed, open access journals, is pleased to announce that today, 17 research articles carried out using genetic data from the Framingham Heart Study (FHS), are being published as a supplement to BMC Medical Genetics.

The collected research, FHS 100K, is the result of cooperation among several research institutions including Boston University School of Medicine and Public Health; the National Heart, Lung and Blood Institute (NHLBI); the National Library of Medicine; and the National Center for Biotechnology Information (NCBI).

FHS 100K will be given unprecedented availability via BioMed Central's open access journal and through NCBI's Database of Genotypes and Phenotypes (dbGaP) http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?id=phs000007. The researchers' decision to publish in BioMed Central's open access journal underlines their collective belief that genetic observations from FHS should be made publicly available and remain an unpatented data resource designed to accelerate scientific discovery.

"BMC Medical Genetics is honored to be the journal which presents these exciting new results to the world," said Melissa Norton, Editor-in-Chief of BMC Medical Genetics. "Inclusion in both our open access journal and in dbGaP will ensure the widest possible access to these materials and will allow researchers to more easily identify high priority findings for replication to build upon the new findings."

The FHS 100K takes its title from the high resolution 100K Affymetrix GeneChip, designed to contain the genetic sequence array of up 100,000 DNA sequences known as single-nucleotide polymorphisms (SNPs). FHS collaborators studied genetic traits, known as phenotypes, and established 8 larger Phenotype Working Groups, overseeing 17 different trait areas including cardiovascular risk factors and biomarkers; subclinical and clinical cardiovascular disease; cancer and longevity; and pulmonary, sleep, neurology, renal and bone domains. Each research article published in the supplement corresponds with one of these areas.

No other study in history has analyzed as many different phenotypic domains as FHS 100K. In addition, many phenotype samples collected through FHS were gathered years before modern therapy and remain undistorted by the effects of contemporary medical treatments, offering pristine samples unattainable in contemporary subjects.

"The Framingham Heart Study 100K effort was made possible by the generosity of our participants who have received examinations and surveillance for almost 60 years," said Dr. Emelia Benjamin, Professor of Medicine at Boston University School of Medicine (BUSM), and Director of the Echocardiography and Vascular Function laboratories at the Framingham Heart Study

Karen Antman, MD, dean of BUSM and provost of Boston University Medical Campus, added, "The Framingham Heart Study dataset is another example of the groundbreaking collaboration of researchers from Boston University Schools of Medicine and Public Health and from the NHLBI. Our researchers make extraordinary contributions that continuously improve the well-being of people all over the world."

Launched in 1948 by National Heart Institute (now NHLBI), the objective of the Framingham Heart Study is to identify the common factors or characteristics that contribute to cardiovascular disease (CVD) by following its development over a long period of time in a large group of participants who had not yet developed overt symptoms of CVD or suffered a heart attack or stroke. The original researchers recruited 5,209 men and women between the ages of 30 and 62 from the town of Framingham, Massachusetts. Those participants have been followed for nearly 60 years and FHS now includes second and third generation participants.

The data from all of the studies will be made available through NHLBI's dbGaP, a database designed to archive and distribute data from genome wide association studies. Researchers around the world will be able to use the results in the database to conduct further research to create new drugs and treatments to benefit patients. In addition, the results from FHS 100K will automatically be transferred from dbGaP into the SNP Health Association Resource (SHARe) project website, a similar database from NHLBI designed for much larger-scale, whole-genome association study. The SHARe project will analyze 550K SNPs in more than 9,000 samples collected by the NHLBI and Boston University School of Medicine for the Framingham Heart Study.

Charlotte Webber | alfa
Further information:
http://www.biomedcentral.com

More articles from Studies and Analyses:

nachricht Researchers simplify tiny structures' construction drip by drip
12.11.2018 | Princeton University, Engineering School

nachricht Mandibular movement monitoring may help improve oral sleep apnea devices
06.11.2018 | Elsevier

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>